Cargando…
Evolution of Knowledge in the Treatment of Long-Standing Atrial Fibrillation in a UK Tennis Champion
During the last several decades, there have been major advances in the evolution of drug therapies for the rate management of atrial fibrillation (AF). Initially, the drug of choice was digoxin but currently, the drug of choice is beta-adrenergic blockers. Drug therapies for stroke prevention in AF...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144072/ https://www.ncbi.nlm.nih.gov/pubmed/34055502 http://dx.doi.org/10.7759/cureus.14624 |